News
55m
Stocktwits on MSNSarepta Pauses DMD Gene Therapy Trial After Second Death; Retail Traders Brush Off RiskRetail investor chatter around Sarepta Therapeutics surged on Sunday after the company announced it had suspended shipments ...
The Kansas City Chiefs have shared a super touching and heartfelt moment with a young Chiefs fan and Patrick Mahomes. The ...
Sarepta Therapeutics said it has temporarily suspended shipments of Elevidys® (delandistrogene moxeparvovec-rokl) for infusion in non-ambulatory patients following the second death in three months of ...
Sarepta Therapeutics ( NASDAQ: SRPT) reported a second fatality from acute liver failure in a patient treated with its gene ...
The estimated cost that Belfast Trust has produced seems high and does not align with any other figures we have seen from ...
Sarepta Therapeutics Inc. said a second patient has died of acute liver failure after being treated with its gene therapy for ...
Sarepta said it was halting shipments of its Duchenne gene therapy for patients who can no longer walk, following the death ...
BASEL, Switzerland I June 15, 2025 I Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today new dosing restrictions, effective immediately, for ELEVIDYS™ ...
Sarepta Therapeutics on Sunday said there had been a second reported case of acute liver failure resulting in death after a patient received the company's gene therapy for a rare form of muscular ...
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today provided a safety ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results